Optimizing Medical Affairs’ Role in CNS / Neurosciences Launches

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Medical Affairs Product Launch in CNS / Neurosciences: Roles, Collaboration, and Evolution”

STUDY OVERVIEW

Navigating the complexities of CNS / Neurosciences product launches demands a strategic rethinking of Medical Affairs roles and collaborative efforts. As this market rapidly advances, Medical Affairs leaders are called to redefine their roles, enhance cross-functional collaboration, and stay agile amidst ongoing industry shifts.

Best Practices, LLC conducted this benchmarking research to examine the evolving role of Medical Affairs in CNS / Neurosciences product launches. The study probes how Medical Affairs can lead with greater impact, drive cross-functional synergy, and adapt to the ever-changing medical environment, ensuring their strategies are as dynamic as the market they serve.

KEY TOPICS

Medical Leadership Roles and Launch Activity Effectiveness in CNS / Neurosciences
Ensuring Cross-functional Alignment and Collaboration in CNS / Neurosciences Launches
Adopting to Ongoing Changes in Medical Landscape

KEY METRICS

Medical Affairs’ role in CNS / Neurosciences launches
Effective Medical Affairs launch activities in CNS / Neurosciences segment
Improvement areas for Medical Affairs around CNS / Neurosciences launches
Medical Affairs’ internal collaboration to ensure successful CNS / Neurosciences launches
Medical Affairs’ cross-functional team role

SAMPLE KEY FINDINGS

Internal Group Collaboration: Medical collaborates early and often with cross-functional launch teams (93%) through clearly defined roles, responsibilities, and expectations (59%) to ensure successful CNS / Neurosciences launches.

METHODOLOGY

This benchmarking study engaged 30 Medical leaders from 25 leading life sciences organizations. The study insights are drawn primarily from Directors and upper management executives, representing nearly 80% of the benchmark class.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Diagnostic; Chemical; Health Care; Consulting; Communications; Consumer Products; Medical Device

Companies Profiled:
Adamas Pharmaceuticals; Apellis Pharmaceuticals; AstraZeneca; BELLUS Health; BIAL; bioMerieux; Boehringer Ingelheim; EMD Serono; Eurofarma; Genentech; Gedeon Richter ; GW Pharmaceuticals; Ipsen; Kyowa Kirin; Labaid Group; Lundbeck; MEDiSTRAVA; Merck KGaA; NexGen Healthcare Communications; Novartis; Pixacore; Sandoz; Sunovion; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Medical Affairs Product Launch in CNS / Neurosciences: Roles, Collaboration, and Evolution

ID: 5818

Features:

Pages/Slides: 31

Published: 2024

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E97CDD54F6391DDC00258B6C004A51C6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-product-launch-in-cns-neurosciences-roles-collaboration-evolution?opendocument
18
19opendocument
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB